Once-daily lixisenatide in combination with basal insulin ± OADs in patients with type 2 diabetes selectively reduces postprandial hyperglycaemic daytime exposure

被引：0
|
作者：
Gomez-Huelgas, R. [1 ]
Riddle, M. C. [2 ]
Seino, Y. [3 ]
Cariou, B. [4 ]
Roy-Duval, C. [5 ]
Hecquet, C. [5 ]
DiGenio, A. [6 ]
Rosenstock, J. [7 ]
机构：
[1] Hosp Reg Univ Carlos Haya, Dept Internal Med, Malaga, Spain
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[3] Kansai Elect Power Hosp, Osaka, Japan
[4] Nantes Univ Hosp, Dept Endocrinol, Paris, France
[5] Sanofi, Paris, France
[6] Sanofi, Bridgewater, MA USA
[7] Dallas Diabet & Endocrine Ctr, Dallas, TX USA
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1005
引用
收藏
页码：S403 / S403
页数：1
相关论文
共 50 条
  • [1] Once-Daily Lixisenatide as Add-On to Basal Insulin ± OADs in Patients With Type 2 Diabetes Selectively Reduces Postprandial Hyperglycemic Daytime Exposure
    Riddle, Matthew C.
    Seino, Yutaka
    Cariou, Bertrand
    Huelgas, Ricardo Gomez
    Roy-Duval, Christine
    Hecquet, Carole
    Digenio, Andres
    Rosenstock, Julio
    [J]. DIABETES, 2013, 62 : A239 - A240
  • [2] Detemir as a once-daily basal insulin in type 2 diabetes
    Nelson, Scott E.
    [J]. CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2011, 3 : 27 - 37
  • [3] iGlarLixi, a titratable once-daily fixed-ratio combination of basal insulin and lixisenatide for intensifying type 2 diabetes management for patients inadequately controlled on basal insulin with or without oral agents
    Skolnik, Neil
    Dupree, Renell S.
    Johnson, Eric L.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (12) : 2187 - 2194
  • [4] Once-daily prandial lixisenatide versus once-daily rapid-acting insulin in patients with type 2 diabetes mellitus insufficiently controlled with basal insulin: analysis of data from five randomized, controlled trials
    Raccah, Denis
    Lin, Jay
    Wang, Edward
    Germe, Maeva
    Perfetti, Riccardo
    Bonadonna, Riccardo C.
    de Pablos-Velasco, Pedro
    Roussel, Ronan
    Rosenstock, Julio
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (01) : 40 - 44
  • [5] Efficacy and Safety of Once-Daily Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Basal Insulin ± Metformin: GetGoal-L Study
    Riddle, Matthew
    Home, Philip
    Marre, Michel
    Niemoeller, Elisabeth
    Ping, Lin
    Rosenstock, Julio
    [J]. DIABETES, 2012, 61 : A251 - A251
  • [6] Efficacy and safety of once-daily lixisenatide in type 2 diabetes insufficiently controlled with basal insulin ± metformin: GetGoal-L study
    Aronson, R.
    Riddle, M.
    Home, P.
    Marre, M.
    Niemoeller, E.
    Ping, L.
    Rosenstock, J.
    [J]. DIABETOLOGIA, 2012, 55 : S8 - S8
  • [7] PREDICTING TREATMENT OUTCOME OF TYPE 2 DIABETES PATIENTS INITIATING ONCE-DAILY BASAL INSULIN INJECTION
    Mohebbi, A.
    Bengtsson, H.
    Jensen, M.
    Stallknecht, B.
    Kjoller, N. -K.
    Morup, M.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A101 - A101
  • [8] Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial
    Cho, Kyu Yong
    Nakamura, Akinobu
    Oba-Yamamoto, Chiho
    Tsuchida, Kazuhisa
    Yanagiya, Shingo
    Manda, Naoki
    Kurihara, Yoshio
    Aoki, Shin
    Atsumi, Tatsuya
    Miyoshi, Hideaki
    [J]. DIABETES & METABOLISM JOURNAL, 2020, 44 (04) : 532 - +
  • [9] Clinical Characteristics of Patients Responding to Once-Daily Basal Insulin Therapy in Korean Subjects with Type 2 Diabetes
    Sun Ok Song
    You-Cheol Hwang
    Kyu-Jeung Ahn
    Bong Soo Cha
    Young Duk Song
    Dae Wook Lee
    Byung-Wan Lee
    [J]. Diabetes Therapy, 2015, 6 : 547 - 558
  • [10] Clinical Characteristics of Patients Responding to Once-Daily Basal Insulin Therapy in Korean Subjects with Type 2 Diabetes
    Song, Sun Ok
    Hwang, You-Cheol
    Ahn, Kyu-Jeung
    Cha, Bong Soo
    Song, Young Duk
    Lee, Dae Wook
    Lee, Byung-Wan
    [J]. DIABETES THERAPY, 2015, 6 (04) : 547 - 558
12345